1. Epizyme’s Tazverik (tazemetostat) Receives the US FDA’s Accelerated Approval as the First Therapy for Epithelioid Sarcoma Published: Jan 23, 2020 | Tags: Epizyme, Tazverik, tazemetostat, Receives, US, FDA, Accelerated Approval, […]readmore
Tags : Indivumed
Shots: The companies enter into precision medicine collaboration to discover and develop first-in-class therapies to treat patients with NSCLC. The companies will share the development cost while Evotec will be […]readmore
Shots: Indivumed to receive upfront from Evotec, for accessing Indivumed’s database “IndivuType” and both companies will jointly invest in data analysis, target identification, validation, and drug discovery. Evotec will be […]readmore